While Insulet Corporation has overperformed by 1.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PODD rose by 12.18%, with highs and lows ranging from $354.88 to $230.05, whereas the simple moving average fell by -2.88% in the last 200 days.
On December 16, 2025, Evercore ISI started tracking Insulet Corporation (NASDAQ: PODD) recommending Outperform. A report published by UBS on November 19, 2025, Upgraded its rating to ‘Buy’ for PODD. Stifel also rated PODD shares as ‘Buy’, setting a target price of $370 on the company’s shares in an initiating report dated October 21, 2025. Oppenheimer Initiated an Outperform rating on September 08, 2025, and assigned a price target of $365. Truist initiated its ‘Buy’ rating for PODD, as published in its report on June 16, 2025. Goldman’s report from May 30, 2025 suggests a price prediction of $380 for PODD shares, giving the stock a ‘Buy’ rating. Wolfe Research also rated the stock as ‘Outperform’.
Analysis of Insulet Corporation (PODD)
Further, the quarter-over-quarter increase in sales is 29.86%, showing a positive trend in the upcoming months.
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Insulet Corporation’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of 19.68% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.14, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and PODD is recording an average volume of 662.92K. On a monthly basis, the volatility of the stock is set at 3.63%, whereas on a weekly basis, it is put at 2.24%, with a loss of -0.44% over the past seven days. Furthermore, long-term investors anticipate a median target price of $381.36, showing growth from the present price of $292.88, which can serve as yet another indication of whether PODD is worth investing in or should be passed over.
How Do You Analyze Insulet Corporation Shares?
Insulet Corporation (PODD) is based in the USA and is one of the most prominent companies operating in the Medical Devices market. When comparing Insulet Corporation shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 84.98, there is a growth in quarterly earnings of 14.88%.
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.42%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 100.45% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
